Plasma plasminogen activator inhibitor (PAI) mass concentration (antigen) forms inactive complexes with tissue plasminogen activator (tPA) so that only part of the total PAI-1 antigen has biologic activity. Studies differ as to the role of PAI-1 for acute myocardial infarction. In 1 study, PAI-1 predicted first acute myocardial infarction (MI) (1), whereas other studies showed a complex interaction with other coronary risk factors for the prediction of cardiovascular disease (2,3). Age, lifestyle coronary risk factors such as smoking and alcohol consumption; anthropometric measurements such as body mass index (BMI), waist:hip ratio (WHR), and intraabdominal fat; diastolic blood pressure (DBP); and biochemical analytes such as triglyceride and insulin concentrations were associated with PAI-1 (4-7).
for the 2 groups of participants (11) . The present cross-sectional study expanded the multiple regression analyses of association between coronary risk factors and PAI-1 activity to evaluate 27 measured coronary risk factors. The aims of the study were to evaluate whether the inclusion changed the significant association between the coronary risk factors and PAI-1 activity, and to evaluate whether persons without coronary heart disease and patients who had survived MI differed regarding the importance of the association for the coronary risk factors.
MATERIALS AND METHODS

Patients
As cases, we included 22 Danish white patients, 19 males and 3 females, who had survived MI diagnosed before they were 41 years old (7, 8) . They were selected among 77 consecutive patients who had been admitted to Herning central hospital and 3 other hospitals in the same region of Jutland, Denmark, between July 1983 and July 1997. The gender distribution of the cases corresponded to that of the group of patients from whom they were recruited. At the time of the study, 41 had died, or moved to other regions, or were lost at followup, or non-responding.
This study included 24 Danish white healthy persons as control persons, 21 males and 3 females, of 84 patients who had been treated for appendicitis or hernia at the central hospital between 1990 and 1996. We selected the control persons so they matched the cases for age and gender.
Clinical examinations were carried out between April and August 1999, at least 2 years after the admission of the participants. At the time of the examinations, the control persons were median 47 years old (range, 34 to 54). The cases were median 45.5 years old (range, 35 to 54). The participants did not have known hypothyroidism, pancreatitis, nephrotic syndrome, or diabetes mellitus, and none of the women were pregnant.
Each participant had given a written informed consent according to the Declaration of Helsinki before they were included in the study, and the protocol was approved by the Science-Ethical Committee of Ringkjoebing County. The Danish Registry Board, Copenhagen, had approved the data register for the study.
Blood Samples and Other Coronary Risk Factors
Each control person and case was examined according to the same protocol. Venous blood samples were collected from an antecubital vein in vacutainer tubes after overnight fast between 8 and 10 AM. For determination of PAI-1, blood was coagulated with NaCitrate. Within 60 minutes after the venous puncture, blood samples for determination of PAI-1 were centrifuged at 1500 g for 10 minutes, and plasma was carefully pipetted off and stored at -20°C . After up to 2 months of storage, the plasma samples from both cases and control persons were measured in 2 runs using the Berichrom assay (BCT, Dade Behring Diagnostics GmbH, Marburg, Germany) (9) . The reference interval for PAI-1 was 0.3 to 3.5 kU/L.
Participants described their working conditions and family history in questionnaire forms. A positive family history implied that at least 1 of the parents, uncles, aunts, and siblings had experienced MI before 55 years of age. Social class was judged according to a Danish classification by Svalastoga as modified by Hansen (10, 11) . We measured height and weight, waist and hip circumferences, total body fat mass by a single dual energy x-ray absorptiometry (DEXA) scanner, the areas of subcutaneous and intraabdominal adipose tissue on an abdominal computed tomography (CT) scan, and systolic blood pressure (SBP) and DBP.
Blood samples were transported to the laboratory for immediate measurements of all analytes except PAI-1 and von Willebrand factor. The following analytes were measured: fasting serum concentrations of total cholesterol, HDL cholesterol, triglyceride, capillary blood glucose, glycosylated hemoglobin, HbA 1c , plasma von Willebrand factor ristocetin cofactor activity, plasma homocysteine concentration, plasma fibrinogen concentration, C-reactive protein (CRP), and urinary albumin concentration. Triglyceride was measured with the VITROS TRIG assay according to the instructions of the manufacturer (Vitros Chemistry). An upper limit for normal triglyceride was less than 1.69 mmol/L. Plasma von Willebrand factor ristocetin cofactor activity was measured using a platelet agglutinin method and the von Willebrand reagent (Dade Behring). The reference interval was 0.65 to 1.25, or 65% to 125% of the norm. Internal quality control implied use of 2 control plasma samples, and the Dade Behring ORKL calibrator was used as standard.
We calculated serum LDL cholesterol concentration by the Friedewall formula and the ratio between the LDL and HDL cholesterol concentrations. The participants were classified according to a binary score of high triglyceride and low HDL cholesterol concentrations, and according to the metabolic syndrome (12) . The WHO definition was slightly modified because we used fasting blood glucose concentration greater than 6.1 mmol/L or HbA 1c ≥ 6.0 or both to indicate impaired glucose homeostasis and insulin resistance.
Statistical Analysis
The sample size of the 2 study groups allowed us to undertake a reliable simultaneous evaluation of 2 to 4 coronary risk factors with a significant association with PAI-1 (13) . Missing data (alcohol consumption [one], social class [two], fasting glucose [one], and triglyceride [one]) were replaced with the median value for cases or control persons, respectively. Statistical analyses were performed using STATA (version 7.0, Stata Corp., College Station, TX). We evaluated the association between coronary risk factors and PAI-1 in univariate and multiple linear regression analyses and undertook separate analyses for cases and controls. The multiple regression models were established with use of the stepwise procedure in STATA and exclusion of variables having p >0.05. All tests were two-sided, and we considered p <0.05 statistically significant. We examined the individual coronary risk factors added to the most significant coronary risk factor(s) in the multiple linear regression analyses.
RESULTS
Study Population
The 2 study groups differed significantly regarding SBD, DBP, total cholesterol, LDL cholesterol, triglyceride, and fibrinogen (10) . However, PAI-1 did not differ significantly between the control persons (median, 2.65 kU/L; range, 1.90 to 7.40) and cases (median, 3.25 kU/L; range, 1.50 to 7.10) (p=0.085, Mann-Whitney U test).
Regression Analyses for Control Persons
Univariate linear regression analyses for the control persons showed that BMI, alcohol consumption, social class, WHR, diastolic blood pressure, intraabdominal adipose tissue, triglyceride, fibrinogen, von Willebrand factor, urinary albumin concentration, and metabolic syndrome were significantly associated with PAI-1. All values of von Willebrand factor but 1 were within the limits of reference range. Triglyceride and von Willebrand factor were significant in multiple linear regression analyses (p=0.0002, R 2 =0.55) ( The regression line shows that median PAI-1 had a threefold increase with an increase of triglyceride from low to high values (Fig. 1A) . Median PAI-1 had a threefold increase with an increase of von Willebrand factor from low to high values (Fig. 1B) . Partial residual plots for triglyceride and von Willebrand factor gave no obvious indication of nonlinearity. A test for heteroskedasticity was negative (p=0.31). Twentythree of 24 control persons had standardized residuals between -2 and 2.
Regression Analyses for Cases
Univariate linear regression analyses for the cases showed that age, systolic blood pressure, intraabdominal adipose tissue, HDL cholesterol, 
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and triglyceride/HDL cholesterol score were significantly associated with PAI-1. The intraabdominal fat and age were significant in multiple regression analyses (p=0.0011, R 2 =0.51) ( Table  1) . For the cases, the equation for the final multiple regression model was:
PAI-1 activity (kU/L) = -2.50 + (0.14 × age (years)) + (0.011 × intraabdominal adipose tissue (cm 2 )) Regression lines showed that median PAI-1 had a twofold increase with a rise from low to high values of age and intraabdominal adipose tissue ( Fig. 2A, 2B) . Partial residual plots for intraabdominal fat and age gave no obvious indication of nonlinearity. A test result for heteroskedasticity was negative (p=0.26). All cases had standardized residuals between -2 and 2. A normal probability plot showed that the distribution of the residuals departed only slightly from normal. 
DISCUSSION
For the healthy control persons, triglyceride concentration and von Willebrand factor activity were significantly associated with PAI-1 activity in multiple linear regression analyses of 27 coronary risk factors. The 2 coronary risk factors explained 55% of the variation of PAI-1. In contrast for the cases, age and intraabdominal adipose tissue were significantly associated with PAI-1 activity. Thus the study supported that PAI-1 is associated with the metabolic syndrome.
Due to small sample size of the study, the design and execution were especially important for the reliability of the findings. We investigated all available participants and measured coronary risk factors. The hospitals provided service for unselected patients with MI. As control persons (and cases) in the present study and a previous Danish case-control study had similar distributions of major coronary risk factors (14) , there was no strong indication of lack of external and internal validity. Thus the hospital-based group of control persons had a pattern of major coronary risk factors like that of a population-based group of control persons. The participants did not have known disorders apart from MI known to influence the level of PAI-1. Several facts support the use of multiple linear regression analyses for the 4 associations between coronary risk factors and PAI-1. The study showed no evidence of significant heteroskedasticity or nonlinearity, and the standardized residuals appeared to be normally distributed with all values but one being between -2 and 2.
Compared with the previous multiple linear regression analyses of 4 measures of body fat for association with PAI-1 (10), the expanded number of coronary risk factors in this evaluation were advantageous. Whereas the previous study found 1 variable was significantly associated with PAI-1 and explained 37% of the variation of PAI-1, this study found that 2 variables were associated with PAI-1 both for cases and controls, and the combinations explained 51% and 55% of the variation of PAI-1. In a Swedish study, coronary risk factors explained only 22% of the variation of PAI-1 (4). Hence, our study gave new insight concerning the clinical background for PAI-1 despite the small sample size.
For the control persons, median PAI-1 increased threefold from the lowest to the highest values of triglyceride and von Willebrand factor. It was no surprise that triglyceride was significantly associated with PAI-1 in healthy persons because the finding is consistent with other reports in the literature (4, (15) (16) (17) (18) (19) (20) . A Swedish study showed a similar threefold increase in PAI-1 from the lowest to the highest quartile of triglyceride (4) . However, to our knowledge, no previous study has indicated that von Willebrand factor was associated with PAI-1. In fact, 2 studies did not find a statistically significant association between von Willebrand factor and PAI-1 like our study did (15, 21) . Due to the discrepancy between the studies, further investigations are warranted.
Our findings differed for the cases where age and intraabdominal adipose tissue produced a twofold increase of PAI-1. These findings are also in accord with those reported previously. PAI-1 increased with age up to 55 years for a large Swedish cohort (22) . Furthermore, the association between intraabdominal adipose tissue and PAI-1 has been described previously. The difference in associations between coronary risk factors and PAI-1 for our control persons and cases is a puzzle that requires further investigation.
This study did not support a similar importance of other previous findings. A large Swedish study showed a significant association between BMI and DBP and PAI-1 (4), but in that study PAI-1 increased only twofold or less from lowest to highest quartiles of these coronary risk factors. Lifestyle coronary risk factors such as smoking and consumption of alcohol had an association with PAI-1 in a Japanese study (9) . In another study, persons with impaired glucose tolerance had a higher PAI-1 than those without (23) . A Danish study found that abdominal subcutaneous adipose tissue had a production of PAI-1 (24) , but in our study neither abdominal subcutaneous adipose tissue nor total fat percentage was significantly associated with PAI-1.
This study has several limitations. It included only a small number of Danish white individuals who predominantly were young adult men. Fasting blood insulin was associated with PAI-1, but was not measured in our study. Cross-sectional investigations do not allow for conclusions as to whether the significant associations imply cause-effect relations. For the cases, we do not know whether MI changed the association between coronary risk factors and PAI-1.
It remains to be shown whether our findings can be reproduced in a larger series of individuals, e.g., with other background features, and whether the observed inter-individual associations can be used to predict intra-individual changes.
In summary for healthy persons, 2 of 27 coronary risk factors were significantly associated with PAI-1, and they explained more than half the variation of PAI-1. Healthy persons and patients with previous MI differed regarding coronary factors associated with PAI-1.
